Real-World Evidence of Safety and Efficacy of Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel in Patients with Advanced Non-Small-Cell Lung Cancer and Preexisting Interstitial Lung Disease: A Retrospective Study

BACKGROUND: Standard chemotherapy for advanced non-small-cell lung cancer (NSCLC) with preexisting interstitial lung disease (ILD) has not yet been established. Although a combination of carboplatin and paclitaxel is most frequently used for patients with advanced NSCLC and ILD, the safety and effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Araya, Tomoyuki, Kita, Toshiyuki, Ueda, Tsukasa, Terada, Nanao, Sakai, Tamami, Yamamura, Kenta, Kurokawa, Koji, Uchida, Yuka, Sone, Takashi, Kimura, Hideharu, Kasahara, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446117/
https://www.ncbi.nlm.nih.gov/pubmed/31015884
http://dx.doi.org/10.1155/2019/5315903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446117/
https://www.ncbi.nlm.nih.gov/pubmed/31015884
http://dx.doi.org/10.1155/2019/5315903

Ejemplares similares